HAMILTON, OH — There are no antibiotics developed to fight the lesser-known acinetobacter baumannii category of bacteria, leaving cleaning and sanitation as the only tools to prevent infection, according to a press release.
According to the release, this type of "gram-negative" bacteria is different from other more recognized bacteria like methicillin-resistant Staphylococcus aureus (MRSA), because the Infectious Diseases Society of America reports that at this time there are no middle- or late-stage clinical trials directed specifically to treating it.
Acinetobacter baumannii most often cause hospital-acquired infections (HAIs) and enters through open wounds, catheters and breathing tubes, the release noted.
Instead, to keep the disease from killing the estimated tens of thousands of hospital patients each year, "proper hand washing is at the top of the list, but right behind it is the need to keep surfaces hygienically clean," according to Kaivac Inc. Communications Manager Matt Morrison, the release stated.
Morrison recommends that hospitals add ATP rapid monitoring systems to their cleaning program, "This way they [can] test surfaces quickly to make sure they are hygienically clean and stay that way."
Click here to read the complete release.